Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The safety of exercise training in multiple sclerosis: A systematic review.
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.
Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide.
Association between multiple sclerosis and chronic periodontitis: a population-based pilot study.
Report of Three Cases of Herpes Zoster During Treatment with Natalizumab.
Investigational Laquinimod Demonstrates Its Potential as a New Oral Treatment For RRMS
Autoinflammatory grey matter lesions in humans: cortical encephalitis, clinical disorders, experimental models.
Multiple sclerosis: a primary care perspective.
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis-Report of Two Cases.
Minocycline in Clinically Isolated Syndromes (CIS) and Early Single Relapse Multiple Sclerosis (MS)
No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
Treatment of human spasticity with delta 9-tetrahydrocannabinol.
Epistasis and immunity: the role of genetic interactions in autoimmune diseases.
Acute relapse after initiation of Siponimod in a patient with secondary progressive MS.
Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.
Transverse myelitis.
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Histamine and neuroinflammation: insights from murine experimental autoimmune encephalomyelitis.
Progressive resistance therapy is not the best way to rehabilitate deficits due to multiple sclerosis: No.
In vitro assessment of the direct effect of laquinimod on basic functions of human neural stem cells and oligodendrocyte progenitor cells.
Riluzole blocks persistent Na+ and Ca2+ currents and modulates release of glutamate via presynaptic NMDA receptors on neonatal rat hypoglossal motoneurons in vitro.
PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews.
Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study.
Treatment with laquinimod reduces development of active MRI lesions in relapsing MS.
Pages
« first
‹ previous
…
174
175
176
177
178
179
180
181
182
…
next ›
last »